Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
48 studies found for:    Open Studies | "Sarcoma, Ewing's"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Sarcoma, Ewing's"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Condition: Sarcoma, Ewing
Intervention: Drug: TK216
2 Recruiting Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Standard treatment (as per protocol ISG SSG III);   Drug: Intensified chemotherapy
3 Recruiting Randomized Phase IIb Trial of Vigil™ Versus Gemcitabine + Docetaxel for Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Biological: Vigil;   Drug: gemcitabine and docetaxel
4 Recruiting Study in Localized and Disseminated Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Zoledronic acid;   Drug: Busulfan;   Drug: Treosulfan
5 Recruiting Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma
Condition: Ewing Sarcoma
Interventions: Drug: Olaparib;   Drug: Temozolomide;   Drug: Irinotecan
6 Recruiting Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Condition: Ewing's Sarcoma
Intervention: Biological: pbi-shRNA™ EWS/FLI1 Type 1 LPX
7 Recruiting ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients With Previously Treated, Incurable Ewing Sarcoma
Condition: Ewing Sarcoma
Interventions: Drug: niraparib;   Drug: Temozolomide;   Drug: Irinotecan
8 Recruiting Protocol for the Treatment of Metastatic Ewing Sarcoma
Condition: Ewing's Sarcoma (ES)
Interventions: Drug: TEMIRI;   Drug: ADM;   Drug: IFO;   Drug: CYC;   Drug: ETO;   Drug: BUMEL;   Drug: VIN
9 Recruiting Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Condition: Newly Diagnosed Ewing Sarcoma
Interventions: Drug: Cyclophosphamide;   Device: Doxorubicin;   Drug: Vincristine;   Device: Ifosfamide;   Drug: Etoposide;   Procedure: Surgery;   Radiation: Radiation Therapy*;   Drug: Temozolomide;   Drug: Irinotecan
10 Recruiting Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Conditions: Ewing Sarcoma;   Rhabdomyosarcoma;   Wilms Tumor
Intervention: Radiation: Stereotactic Body Radiotherapy (SBRT)
11 Recruiting Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Conditions: Askin Tumor;   Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Intervention: Other: laboratory biomarker analysis
12 Recruiting A Two-Part Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma
Condition: Relapsed or Refractory Medulloblastoma (MB) [Part A: Also Include Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)]
Interventions: Drug: TB-403 20mg/kg;   Drug: TB-403 50mg/kg;   Drug: TB-403 100mg/kg;   Drug: TB-403 ≤175mg/kg
13 Recruiting Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas
Conditions: Ewing Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma
Intervention: Biological: Expanded , Activated NK cells
14 Recruiting Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody
Conditions: Ewing Family of Tumors;   Melanoma;   Neuroblastoma;   Osteosarcoma
Intervention:
15 Recruiting A Study of IMRT in Primary Bone and Soft Tissue Sarcoma
Conditions: Soft Tissue Sarcoma, Adult;   Ewing Sarcoma;   Bone Sarcoma;   Chordoma
Intervention: Radiation: Intensity modulated radiotherapy (IMRT)
16 Recruiting Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Conditions: Osteosarcoma;   Ewing Sarcoma;   Rhabdomyosarcoma;   Soft Tissue Sarcoma
Interventions: Drug: nab-Paclitaxel;   Drug: Gemcitabine
17 Recruiting A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Conditions: Ewing Sarcomas;   Chondrosarcomas;   Osteosarcomas;   Chondroma
Interventions: Drug: Regorafenib;   Drug: Placebo
18 Not yet recruiting Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
Conditions: Cancer;   Toxicity Due to Chemotherapy;   Sarcoma;   Osteosarcoma;   Lymphoma;   Ewing Sarcoma
Intervention: Drug: Triptorelin (GnRHa) + Chemotherapy
19 Not yet recruiting HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
Conditions: Rhabdomyosarcoma;   Neuroblastoma;   Sarcoma;   Sarcoma, Ewing;   Osteosarcoma
Interventions: Drug: Doxorubicin HCl liposomal injection;   Device: Philips Sonalleve MR-HIFU Hyperthermia
20 Recruiting Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
Conditions: Recurrent or Refractory Solid Tumors;   Ewing Sarcoma;   Rhabdomyosarcoma;   Neuroblastoma;   Osteosarcoma
Intervention: Drug: MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.